Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132862 | PMC |
| http://dx.doi.org/10.1055/s-0042-1759849 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Simulated low-dose dark-field radiography for detection of COVID-19 pneumonia.
PLoS One
December 2024
Chair of Biomedical Physics, Department of Physics & School of Natural Sciences, Technical University of Munich, Garching bei München, Germany.
Background: Dark-field radiography has been proven to be a promising tool for the assessment of various lung diseases.
Purpose: To evaluate the potential of dose reduction in dark-field chest radiography for the detection of the Coronavirus SARS-CoV-2 (COVID-19) pneumonia.
Materials And Methods: Patients aged at least 18 years with a medically indicated chest computed tomography scan (CT scan) were screened for participation in a prospective study between October 2018 and December 2020.
Risk factors affecting the development of pneumothorax in patients followed up in intensive care with a diagnosis of COVID-19.
BMC Infect Dis
November 2024
Department of Critical Care, Marmara University Pendik Training and Research Hospital, Pendik, Istanbul, Turkey.
Article Synopsis
- Pneumothorax is a rare but serious complication of COVID-19 that leads to worse patient outcomes, requiring more respiratory support, longer hospital stays, and increased mortality.
- This observational study reviewed 100 patients in the COVID-19 ICU who underwent tube thoracostomy due to pneumothorax, analyzing their demographics and clinical data.
- Findings indicated that the majority of patients were older males (median age 68), with high rates of intubation and significant respiratory support needed, highlighting critical factors that could predict mortality in these cases.
Background Early risk stratification of COVID-19 may yield a better prognosis by tailoring effective treatment strategies. Recent studies have identified that elevated carcinoembryonic antigen (CEA) has prognostic value in terms of disease severity and mortality in patients with pneumonia. This study aims to explore the potential of CEA as a marker for both severity assessment and mortality prediction in COVID-19 patients.
View Article and Find Full Text PDFAcute kidney injury and mortality in patients with critical COVID-19 in Mexico: case-control study.
Cir Cir
October 2024
Health Services of the State of Queretaro.
Objective: We aimed to test the association between acute kidney injury (AKI) and mortality in critically ill patients with Coronavirus disease 2019 (COVID-19).
Method: We conducted a single-center case-control study at the intensive care unit (ICU) of a second-level hospital in Mexico. We included 100 patients with critical COVID-19 from January to December 2021, and collected demographic characteristics, comorbidities, APACHE II, SOFA, NEWS2, and CO-RADS scores at admission, incidence of intrahospital complications, length of hospital and ICU stay, and duration of mechanical ventilation, among others.
Background The post-pandemic phase of the coronavirus infectious disease that emerged in 2019 (COVID-19) has necessitated updates in radiology, with emerging evidence suggesting tracheobronchial wall thickness as a potential new diagnostic marker. Purpose To evaluate the accuracy of chest computed tomography (CT) scans in identifying COVID-19 by assessing tracheobronchial wall thickness in mid-2023. Material and methods A retrospective review was conducted on 60 patients who underwent thoracoabdominal CT and the severe acute respiratory syndrome coronavirus (SARS-CoV-2) antigen tests during emergency visits between June and August 2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!